19:50 EDT X4 Pharmaceuticals (XFOR) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XFOR:
- X4 Pharmaceuticals announces 1-for-30 reverse stock split
- X4 Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
- X4 Pharmaceuticals: Strong Buy Rating Backed by Promising Drug Commercialization and Robust Financial Health
- X4 Pharmaceuticals Reports 2024 Financial Results
- X4 Pharmaceuticals reports Q4 EPS (20c) vs. (10c) last year